• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Device Problems Obstruction of Flow (2423); Malposition of Device (2616)
Patient Problem Obstruction/Occlusion (2422)
Event Type  Injury  
Manufacturer Narrative
As reported in a research article, the amplatzer duct occluder was protruding unto the aortic isthmus causing an gradient.The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
It was reported through a research article identifying amplatzer duct occluder i that may be related to an intervention post procedure.Details are listed in the article, titled "a beneficial technique for preventing the device protrusion to the aorta during percutaneous patent ductus arteriosus closure: ¿balloon-assisted device releasing technique.¿ it was reported in the article that 155 infants underwent patent ductus arteriosus closure with an amplatzer duct occluder i device between january 2012 and december 2018.The mean age of the patient was 1.39 years old, with a mean weight of 8.75 kg.82 of the patients were female.All patients had a krichenko classification type a duct.Case 1: one of the patient has pulmonary hypertension and short ampulla/small isthmust.The physician had difficulty placing the device and a pulling maneuver technique was used for optimal device positioning.The device was found to be protruding into the aortic isthmus and causing a gradient of 10mmhg or more.The device was repositioned with low profile balloon catheter and a surgical intervention was performed.
 
Manufacturer Narrative
Correction information for d2.Additional information for g4, g7, h2, h10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER DUCT OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key10012432
MDR Text Key189978266
Report Number2135147-2020-00170
Device Sequence Number1
Product Code MAE
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Remedial Action Replace
Type of Report Initial,Followup
Report Date 12/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/29/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received11/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age1 YR
Patient Weight9
-
-